Companies Olympus Corporation and Investment Fund Rehabilitation Health Care Capital has announced the establishment of a joint venture called Swan Endosorgical Robotics, aimed at developing a modern endolaminal robotic system for gastrointestinal diagnosis and treatment of gastrointestinal diseases (GI).
The project includes investment of up to $ 458 million, which transmits enterprise control to restore, while the Olympus maintains the right to buy the company at a default price. The goal of this project is to improve the current methods of digestive system endoscopic examination, making the procedure less painful and more efficient.
This new system promises to dramatically improve diagnostic standards for gastric and intestinal cancer due to increased precision precision during manipulation within the patient’s body. According to experts, these techniques will facilitate the functioning of doctors, reduce the workload of surgeons, and improve the recovery of patients after the procedure.
This innovation begins with great potential for medical practice. So far, most of the modern endo scoops have been manually carried out, limiting the capabilities of doctors and reducing the effectiveness of intervention. Now, thanks to the development of surgery with the help of robots, patients are expected to have more relief and less complications for patients.
Interestingly, the appearance of a robotic platform in the medicine is no longer uncommon. For example, a famous surgical robot manufacturer, intuitive surgical, actively develops his product line. Their platform has become a standard in devene surgical devices. But the competition is on the rise: new players presenting unique solutions are entering the market.
One of them puts the endocrost robotics project, and develops its own enduluminal robotic system. Although it is unclear to what extent the two projects have developed, the price of serious investors and the higher market indicates significant progress.
But what is the significance of these innovations globally? According to analysts, the worldwide market for robotic medicine will exceed $ 100 billion by 2030. According to data from the Mac Cancity Global Institute, the number of operations using robots increases a dozen percent annually. The new system of health care is changing the effects of modern health care.
Today, the drug is moving towards personal treatment where high -tech tools centers for the exact effect on the affected organs come to the stage. The robotic system fits the idea of future drugs, which was considered impossible before.
Of course, any innovation requires a thorough test and certificate. Medical devices are strictly controlled by international organizations, such as the FDA in the United States and Russia, as Roszdonadzor. Any change in this field goes through long tests and clinical trials.
The summary is that cooperation between Olymps and Rehabilitation begins a new era in the development of robotized endoscopy. Despite many steps and necessary research, the move is already creating a lot of interest in the medical community and is an important contribution to the development of 21st century medicines.
Visit our website to find workers for any production or even personal assistants in the form of high manufacturers robot! https://jobTorob.com/
PS: Image developed by the nerve network
